ClinConnect ClinConnect Logo
Search / Trial NCT03829280

Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Jan 31, 2019

Trial Information

Current as of June 04, 2025

Completed

Keywords

Schizophrenia Cognitive Adaptation Training Functional Outcome

ClinConnect Summary

Schizophrenia remains one of the most disabling conditions world-wide with an economic burden that exceeded $155 billion dollars in fiscal year 2013 alone. Despite existing medication and community treatment, many individuals with this diagnosis continue to have poor outcomes and struggle toward recovery. CAT is a psychosocial treatment using environmental supports such as signs, alarms, pill containers, checklists, technology and the organization of belongings established in a person's home or work environment to bypass the cognitive and motivational difficulties associated with schizophre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Males and females who have given informed consent.
  • 2. Between the ages of 18 and 65.
  • 3. Clinical Diagnosis of Schizophrenia, or Schizoaffective Disorder
  • 4. Able to provide evidence of a stable living environment (individual apartment, family home, board and care facility) within the last three months and no plans to move in the next year.
  • 5. Able to understand and complete rating scales and assessments.
  • 6. Agree to home visits
  • 7. Be able to have reimbursed home visits as part of treatment
  • Exclusion Criteria:
  • 1. Alcohol or drug or dependence within the past 2 months.
  • 2. Currently being treated by an Assertive Community Treatment (ACT) team.
  • 3. History of assault within the past year or other conditions that in the judgement of the treatment team make home visits unsafe.

About The University Of Texas Health Science Center At San Antonio

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical institution dedicated to advancing health through education, research, and patient care. As a prominent sponsor of clinical trials, UT Health San Antonio focuses on innovative medical research aimed at improving health outcomes across diverse populations. With a commitment to excellence, the institution fosters collaboration among its multidisciplinary teams to explore cutting-edge therapies and interventions. Through rigorous scientific inquiry and ethical practices, UT Health San Antonio strives to make meaningful contributions to the field of medicine and enhance the quality of life for patients.

Locations

Manchester, New Hampshire, United States

Lauderdale Lakes, Florida, United States

Granite City, Illinois, United States

Dayville, Connecticut, United States

Lawrenceburg, Indiana, United States

Eugene, Oregon, United States

Providence, Rhode Island, United States

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Dawn Velligan, PhD

Principal Investigator

University of Texas

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials